Privacy
FAQ
Login
Sign up
MENU
Current projects
View all
>
Manager
Nurse
Pharmacist
Physician
Surgeon
Other
How to get involved
Why take part in research
Terms and Conditions
Blog
Field Scope Int
Clinical trial
Republic of Taiwan: Non-small cell lung cancer treatment options
As soon as possible
Republic of Taiwan
To be disclosed by the client
Find out more
Clinical trial
Korea: Non-small cell lung cancer treatment options
As soon as possible
Korea
To be disclosed by the client
Find out more
Clinical trial
United States: Non-small cell lung cancer treatment options
As soon as possible
United States
To be disclosed by the client
Find out more
Clinical trial
Australia: Non-small cell lung cancer treatment options
As soon as possible
Australia
To be disclosed by the client
Find out more
Clinical trial
US: Diabetic Macular Edema (DME)
As soon as possible
US
To be disclosed by the client
Find out more
Sondaggio on-line
Indagine con pazienti oncologici di sesso maschile di età superiore ai 50 anni
Italia
20€
Find out more
Encuesta en línea
Tratamiento de oncología oral
España
20€
Find out more
Online-Umfrage
Orale onkologische Behandlung
Deutschland
20€
Find out more
Online survey
Oral oncology treatment
UK
£20/20EUR
Find out more
Clinical trial
US: Influenza, RSV, and SARS-CoV-2 vaccines
As soon as possible
US
To be disclosed by the client
Find out more
Clinical trial
UK: Influenza, RSV, and SARS-CoV-2 vaccines
As soon as possible
UK
To be disclosed by the client
Find out more
Clinical trial
Australia: Influenza, RSV, and SARS-CoV-2 vaccines
As soon as possible
Australia
To be disclosed by the client
Find out more
Clinical Trial
US: Most effective dose of vaccine for preventing Cytomegalovirus (CMV)
As soon as possible, until December 2023
United States
To be disclosed by the client
Find out more
Clinical Trial
Canada: Most effective dose of vaccine for preventing Cytomegalovirus (CMV)
As soon as possible, until December 2023
Canada
To be disclosed by the client
Find out more
Online community
Erectile Dysfunction
19th and 20th January 2023
US, Nationwide
$280
Find out more
« Previous Page
1
2
3
4
5
Next Page »
We are
Proud members and holders of: